GenAns Biotech Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series C

  • Latest Deal Amount
  • $59M

  • Investors
  • 16

GenAns Biotech General Information

Description

Developer of gene therapy and biopharmaceutical therapeutics designed to address central nervous system and ophthalmic diseases with significant unmet clinical needs. The company offers neurobiology research capabilities, gene therapy technologies, drug development platforms, and a therapeutic pipeline, enabling patients with neurological and ophthalmic disorders to access novel treatment approaches and expanded therapeutic possibilities.

Contact Information

Website
www.genansco.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 301, 3rd Floor, Building 3
  • Number 8 Xuezhi Road, Life Science Park, Changping District
  • Beijing, 102200
  • China
+86 010
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • Room 301, 3rd Floor, Building 3
  • Number 8 Xuezhi Road, Life Science Park, Changping District
  • Beijing, 102200
  • China
+86 010

GenAns Biotech Timeline

2023202420252026
Date FoundedFinancing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

GenAns Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series C) 30-Jul-2026 $59M Completed Generating Revenue
4. Later Stage VC (Series C) 14-Jan-2026 Completed Generating Revenue
3. Early Stage VC (Series B) 08-Jan-2025 Completed Generating Revenue
2. Early Stage VC (Series A) 17-Jan-2024 $14.3M Completed Generating Revenue
1. Seed Round 27-Dec-2022 $14.3M $14.3M Completed Startup
To view GenAns Biotech’s complete valuation and funding history, request access »

GenAns Biotech Investors (16)

Investor Name Investor Type Holding Investor Since Participating Rounds
China Taiping Investment Venture Capital Minority
CITIC Capital Asset Manager Minority
Fortune Capital Venture Capital Minority
Gaorong Ventures Venture Capital Minority
Biossom Investment Management Venture Capital Minority
You’re viewing 5 of 16 investors. Get the full list »

Ready to get started?

Request a free trial

GenAns Biotech FAQs

  • When was GenAns Biotech founded?

    GenAns Biotech was founded in 2022.

  • Where is GenAns Biotech headquartered?

    GenAns Biotech is headquartered in Beijing, China.

  • What industry is GenAns Biotech in?

    GenAns Biotech’s primary industry is Drug Discovery.

  • Is GenAns Biotech a private or public company?

    GenAns Biotech is a Private company.

  • What is GenAns Biotech’s current revenue?

    The current revenue for GenAns Biotech is .

  • How much funding has GenAns Biotech raised over time?

    GenAns Biotech has raised $73.3M.

  • Who are GenAns Biotech’s investors?

    China Taiping Investment, CITIC Capital, Fortune Capital, Gaorong Ventures, and Biossom Investment Management are 5 of 16 investors who have invested in GenAns Biotech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process